November 16, 2013

NIH Study Finds Patients at High-Risk for Developing Wet AMD Benefit from ForeseeHome Monitoring System

by

NIH Study Finds Patients at High-Risk for Developing Wet AMD Benefit from ForeseeHome Monitoring System

Results of the Home Monitoring of the Eye (HOME) study, show that participants at high risk for developing wet age-related macular degeneration (wAMD) using the ForeseeHome monitoring device strategy had significantly better preservation of their visual acuity than those used standard monitoring techniques.
The HOME Study was a collaborative effort led by the National Eye Institute (NEI) to evaluate the performance of Notal Vision’s ForeseeHome device and self-monitoring strategy. 87% of eyes in the ForeseeHome device arm of the study maintained visual acuity of 20/40 or better compared to 62% in the standard care alone arm. Median acuity among device users at the time of choroidal neovascularization (CNV) diagnosis was 20/32.
Among individuals using standard care methods for monitoring, only 55% of those that progressed noted symptoms at home that led them to request an examination. 80% of the participants in the device monitoring group returned sooner than a scheduled appointment, due to a change found by the device or to self-monitoring. This was associated with a greater degree of vision preservation at CNV diagnosis among individuals who returned promptly for examination.
Access the HOME Study report.

We offer resources and free materials for those living with low vision.

View Resources